David
Wong, MD, MSc, FRCS
David Wong, MD, MSc, FRCS
![]()
Consulting: Spine Stabilization Technologies (A), Travena (None, Outside 12-Month Requirement); Other: Presbyterian St Lukes Medical Center (B); Research Support (Staff and/or materials): Mesoblast (B, Paid directly to institution/employer); Royalties: Lippincott Williams And Wilkins (A); Scientific Advisory Board: United Healthcare (B); Stock Ownership: Denver Integrated Imaging (5%), Denver Spine Real Estate Investments (33%), GC OCT (33%), Huron Shores (50%), Impulse (5 Shares), Neuro Interpretive Services (5 Shares), OCC Imaging (2%), PRO GC (33%), Verus (80%).
Sessions :